Clinical Trial Design Optimization and Problem Solving
BTC6213 / 4 q.h.
Formerly BT 3213.
Discusses quantitative data analysis in creating dynamic drug-disease models, strategic market models, trial simulation models, and integrated financial models, which enable key variable analysis in clinical trial developments in real time. This integrated approach allows all decisions in the design to optimize value against both scientific and business criteria simultaneously and continuously. Offers students an opportunity to learn to take a complete view of the development process at the outset—across time, across the portfolio, and at all levels in the organization. This allows for greater insight into a drug’s potential early in the process and leads to a more focused program for promising compounds, including an optimized clinical trial design. It also allows for earlier cessation of unpromising clinical trials, saving time and funds.
There are no current sections scheduled for this course number. Please note that courses have been assigned new numbers beginning with the fall term. Please check the new course number for course availability.
|